Evidence map›Paper›PMID 40800843›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2025

BrainAgeNeXt: Advancing brain age modeling for individuals with multiple sclerosis.

Francesco La Rosa, Jonadab Dos Santos Silva, Emma Dereskewicz, Azzurra Invernizzi, Noa Cahan, Julia Galasso, Nadia Garcia, Robin Graney, Sarah Levy, Gaurav Verma and 7 more

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Francesco La RosaWindreich Department of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-9224-4664
Jonadab Dos Santos SilvaDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-4216-333X
Emma DereskewiczDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Azzurra InvernizziDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Noa CahanBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Julia GalassoDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Nadia GarciaDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Robin GraneyDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-3226-6490
Sarah LevyDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Gaurav VermaBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Priti BalchandaniBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0001-7709-5835
Daniel S ReichTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.ORCID https://orcid.org/0000-0002-2628-4334
Megan HortonDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-8139-5918
Hayit GreenspanBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0001-6908-7552
James SumowskiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0001-6111-4907
Merixtell Bach CuadraCIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Erin S BeckDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Funding

Multimodal MRI in Multiple SclerosisZIANS003119 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI REICH, DANIEL · 2010 to 2025
$53.4M
Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Longitudinal study of metal mixtures and the developmental origins of adolescent risk-takingR01ES028927 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Megan K Horton · 2018 to 2026
$5.3M
7T MRI to reveal structural, connectomic and metabolic imaging markers for the neurobiology of depressionR01MH109544 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BALCHANDANI, PRITI · 2016 to 2020
$2.1M
Intramural NIH HHS ZIA NS003119NCATS NIH HHS UL1 TR004419NIEHS NIH HHS R01 ES028927NIMH NIH HHS R01 MH109544
6 · The paper itself

Abstract

Aging is associated with structural brain changes, cognitive decline, and neurodegenerative diseases. Brain age, an imaging biomarker sensitive to deviations from healthy aging, offers insights into structural aging variations and is a potential prognostic biomarker in neurodegenerative conditions. This study introduces BrainAgeNeXt, a novel convolutional neural network inspired by the MedNeXt framework, designed to predict brain age from T1-weighted magnetic resonance imaging (MRI) scans. BrainAgeNeXt was trained and validated on 11,574 MRI scans from 33 private and publicly available datasets of healthy volunteers, aged 5 to 95 years, imaged with 3T and 7T MRI. Performance was compared against three state-of-the-art brain age prediction methods. BrainAgeNeXt achieved a mean absolute error (MAE) of 2.78 ± 3.64 years, lower than the compared methods (MAE range 3.55-4.16 years). We also tested all methods across different levels of image quality, and BrainAgeNeXt performed well even with motion artifacts and less common 7T MRI data. In three longitudinal multiple sclerosis (MS) cohorts (273 individuals), brain age was, on average, 4.21 ± 6.51 years greater than chronological age. Longitudinal analysis indicated that brain age increased by 1.15 years per chronological year in individuals with MS (95% CI = [1.05, 1.26]). Moreover, in early MS, individuals with worsening disability had a higher annual increase in brain age compared to those with stable clinical assessments (1.24 vs 0.75,

Indexed as

agingbrain agedeep learningmachine learningMRImultiple sclerosis

Identifiers

PMID40800843
PMCPMC12319810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.